Ownership history in MPM BioImpact LLC · 22 quarters on record
This page tracks every 13F SEC filing in which MPM BioImpact LLC reported a position in Repare Therapeutics, Inc. (RPTX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | UNCHANGED | 819,924 | — | 0% | 0.24% | $1.4M | $1.76 |
| 2025 Q2 | UNCHANGED | 819,924 | — | 0% | 0.20% | $1.1M | $1.39 |
| 2025 Q1 | REDUCED | 819,924 | -411,230 | -33.4% | 0.14% | $808K | $0.99 |
| 2024 Q4 | REDUCED | 1,231,154 | -408,695 | -24.9% | 0.23% | $1.6M | $1.31 |
| 2024 Q3 | UNCHANGED | 1,639,849 | — | 0% | 0.85% | $5.6M | $3.44 |
| 2024 Q2 | UNCHANGED | 1,639,849 | — | 0% | 0.84% | $5.4M | $3.30 |
| 2024 Q1 | UNCHANGED | 1,639,849 | — | 0% | 1.24% | $7.7M | $4.71 |
| 2023 Q4 | UNCHANGED | 1,639,849 | — | 0% | 2.80% | $12.0M | $7.30 |
| 2023 Q3 | UNCHANGED | 1,639,849 | — | 0% | 5.29% | $19.8M | $12.08 |
| 2023 Q2 | UNCHANGED | 1,639,849 | — | 0% | 3.49% | $17.3M | $10.58 |
As of 2025 Q4 — sorted by position size